4-Hydrazinobenzenesulfonamide Hydrochloride CAS 17852-52-7
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 4-Hydrazinobenzenesulfonamide hydrochloridi (CAS: 17852-52-7) cum qualitate media Celecoxib (CAS: 169590-42-5).Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Celecoxib Intermedia,Please contact: alvin@ruifuchem.com
Nomen chemicum | 4-Hydrazinobenzenesulfonamide Hydrochloride |
Synonyma | 4-SPH;4-SAPH.HCl;4-Hydrazinobenzene-1-Sulfonamide Hydrochloride;4-Sulfonamidophenylhydrazine hydrochloride;4-Sulfonamidephenylhydrazine HCl;(4-Sulfamoylphenyl) hydrazinum hydrochloridum |
Stock Status | In Stock, Commercial Productio |
CAS Number | 17852-52-7 |
Formulae hypotheticae | C6H9N3O2S·HCl |
M. Pondus | 223.68 g/mol |
Liquescens punctum | 210.0~ 213.0℃(lit.) |
Density | 1.644 (ad 20℃) |
Sensitiva | Hygroscopic |
Aqua Solubility | Solutum in aqua |
COA & MSDS | Praesto |
Sample | Praesto |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Items | Signa inspectionis | Proventus |
Aspectus | Lumen Yellow ut pallide Brown pulveris | Obsequitur |
Liquescens punctum | 210.0~ 213.0℃ | 211.2℃ |
Damnum in Siccatio | <1.00% | 0.25% |
Cinis Content | <0.50% | 0.11% |
una immunditia | <0.50% | Obsequitur |
Totalis immunditias | <2.00% | 0.51% |
Metalla gravia (Pb) | ≤20ppm | <10ppm |
Puritas / Analysis Methodus | >98.0% (HPLC) | 99.49% |
1H NMR Imaginum | Congruunt Structure | Obsequitur |
conclusio | Productum probatum est et cum datis specificationibus obsequitur | |
Applicationem | Medium Celecoxib (CAS: 169590-42-5) |
Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Hygroscopic.Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.Repone ab agentibus oxidentibus, aquae/umoris et bases.A sole abstinete;ignem vitare.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Periculum Codes | R22 - noxia absorptus |
R36/37/38 - irritans ad oculos, systema respiratorium et cutis | |
Salus Descriptio | S36 - gere idoneam tutelam indumentis |
S24/25 - contactus cum cute et oculos fuge | |
WGK Germania | 3 |
RTECS | DA9380000 |
HS Code* | 2935900090 |
Aleam Nota | Irritant |
4-Hydrazinobenzenesulfonamide hydrochloride (CAS: 17852-52-7), intermedium pharmaceuticum, maxime adhibitum in productione Celecoxib (CAS: 169590-42-5).Celecoxib et Rofecoxib sunt duo inhibitores specifici cyclooxygenaseos-2 (COX-2) communiter adhibiti in clinic nunc.Feliciter amplificata sunt a comitatu GD Searle & Pfizer in Civitatibus Foederatis et in anno 1999 venundati sunt, nomina eorum commercia: Celebrex.Celebrex, hoc productum habet effectus analgesicos et anti-inflammatores significantes, et incidentia ulcerum gastrointestinalium superiorum et alia complicationes infimus est.Celecoxib medicamentum non steroidale anti-inflammatorium est, quod effectus anti-inflammatorios et analgesicos exercet, inhibendo COX-2 ad impediendam synthesim prostaglandinorum ab acido arachidonico.Amet acuta et chronica osteoarthritis et arthritis rheumatoideis curationi apta est.